Rush University Medical Center has new restrictions regarding visitors and is adjusting non-urgent scheduled appointments. For information about COVID-19, see the latest updates and our FAQs. Rush accepts donations to support systemwide response efforts, frontline staff, and patients and families.

Excellence is just the beginning.


French German Italian Portuguese Russian

Skin Cancer Services — Clinical Trials

Treatment Study For Patients With Advanced BRAFV600 Mutant Melanoma

Dabrafenib + trametinib followed by ipilimumab + nivolumab at progression or ipilimumab + nivolumab followed by dabrrafenib + trametinib at progression in patients with advanced BRAFV600 mutant melanoma.

Treatment Study for Patients with Merkel Cell Carcinoma

EA6174: STAMP: Surgically treated adjuvant Merkel cell carcinoma with pembrolizumab: A phase III trial.

Treatment Study for Patients with Metastatic Merkel Cell Carcinoma

A phase 2 study of INCMGA00012 in patients with metastatic merkel cell carcinoma.